Literature DB >> 30277589

2-deoxy-D-glucose augments photodynamic therapy induced mitochondrial caspase-independent apoptosis and energy-mediated autophagy.

Xiaolan Feng1, Yin Shi1, Lifen Xie1, Kun Zhang1, Xiaobing Wang1, Quanhong Liu1, Pan Wang1.   

Abstract

OBJECTIVES: Compared to normal cells, malignant cells have a high degree of aerobic glycolysis, also known as the Warburg effect. Therefore, supplementing photodynamic therapy (PDT), an established cancer therapy, with metabolic inhibitors can augment the mitochondrial damage by depleting ATP. To assess the combined impact of the glycolysis inhibitor 2-deoxy-D-glucose (2-DG) and PDT on apoptosis and autophagy in human breast cancer cells, and examine the molecular basis.
METHODS: Calcium-AM/PI double staining was used to evaluate cell viability. Reactive oxygen species (ROS), mitochondria membrane potential (MMP), nuclear morphology, and autophagosomes were measured using specific fluorescent markers. In addition, translocation of the apoptosis inducing factor (AIF) from the mitochondria to nucleus was imaged by confocal laser scanning microscopy, and DNA fragmentation was measured using PI staining and comet assay. PGC-1α expression, oxidative phosphorylation, ATP levels, and autophagy related proteins were detected by qRT-PCR, seahorse bioscience XFP extracellular flux analyzer, and Western blotting, respectively.
RESULTS: Compared to with either monotherapy, 2-DG+PDT resulted in significantly higher cytotoxicity in the three breast cancer cell lines (MDA-MB-231, MCF-7, and 4T1), which was consistent with tumor growth regression trends seen in the 4T1 xenograft model. A synergistic augmentation of mitochondrial dysfunction (in terms of ROS generation, MMP loss, and PGC-1α down-regulation) and ATP depletion was seen in cells receiving 2-DG and PDT. In addition, nuclear translocation of AIF and the subsequent DNA damage indicated that the cytotoxic effects were mediated by a caspase-independent mechanism, which was relieved by the ROS scavenger N-acetylcysteine. Autophagy via the AMP-activated protein kinase (AMPK) was also observed following 2-DG+PDT, and reversed upon pre-treatment with the autophagy inhibitor 3-methyladenine.
CONCLUSIONS: The anti-cancer effects of 2-DG+PDT are mediated by both mitochondria triggered apoptosis and AMPK-mediated autophagy. Lasers Surg. Med.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  2-deoxy-D-glucose; apoptosis; autophagy; breast cancer; photodynamic therapy

Year:  2018        PMID: 30277589     DOI: 10.1002/lsm.23020

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  5 in total

1.  4-hexylresorcinol-induced protein expression changes in human umbilical cord vein endothelial cells as determined by immunoprecipitation high-performance liquid chromatography.

Authors:  Yeon Sook Kim; Dae Won Kim; Seong-Gon Kim; Suk Keun Lee
Journal:  PLoS One       Date:  2020-12-15       Impact factor: 3.240

Review 2.  Autophagy Regulation and Photodynamic Therapy: Insights to Improve Outcomes of Cancer Treatment.

Authors:  Waleska K Martins; Renata Belotto; Maryana N Silva; Daniel Grasso; Maynne D Suriani; Tayná S Lavor; Rosangela Itri; Mauricio S Baptista; Tayana M Tsubone
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

Review 3.  The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.

Authors:  Kangchen Chen; Chenzhi Zhang; Sunbin Ling; Rongli Wei; Jianguo Wang; Xiao Xu
Journal:  Cell Death Dis       Date:  2021-09-04       Impact factor: 8.469

4.  Microarray analysis of breast cancer gene expression profiling in response to 2-deoxyglucose, metformin, and glucose starvation.

Authors:  Rita Aoun; Christopher El Hadi; Roula Tahtouh; Rita El Habre; George Hilal
Journal:  Cancer Cell Int       Date:  2022-03-19       Impact factor: 5.722

5.  Metformin induces caspase-dependent and caspase-independent apoptosis in human bladder cancer T24 cells.

Authors:  Ji Hoon Jang; Eon-Gi Sung; In-Hwan Song; Tae-Jin Lee; Joo-Young Kim
Journal:  Anticancer Drugs       Date:  2020-08       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.